Search Within

David Nemirovsky

Formats
  1. Meeting Abstract (34)
  2. Journal Article (13)
  3. Research Letter (2)
Groups
  1. Epidemiology and Biostatistics (49)
  2. Biostatistics Service (48)
  3. Department of Medicine (43)
  4. Population Sciences Research Program (37)
  5. Graduate Medical Education (36)
  6. Hematologic Malignancies, Division of (36)

More Groups

People
  1. Andriy Derkach (33)
  2. Saad Usmani (23)
  3. Sergio Giralt (23)
  4. Carlyn Rose Tan (22)
  5. Gunjan Shah (22)
  6. Michael Scordo (22)

More People

Years
  1. 2025 (3)
  2. 2024 (23)
  3. 2023 (21)
  4. 2022 (2)
Publications
  1. Blood (22)
  2. Clinical Lymphoma, Myeloma and Leukemia (7)
  3. Blood Advances (3)
  4. Blood Cancer Journal (3)
  5. Journal of Clinical Oncology (3)
  6. Transplantation and Cellular Therapy (3)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Elsevier Inc. (10)
  3. American Society of Clinical Oncology (4)
  4. Nature Publishing Group (3)
  5. Oxford University Press (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Health-related values discussions with patients undergoing allogeneic and autologous stem cell transplant: Feasibility and acceptability of an early primary palliative care intervention
    Journal Article

    Cohen, A. G.; Cho, C.; Patterson, E.; Magaldi, J.; Doga, T.; Naputo, K.; Alvarez, K.; Giles, E.; Yang, G.; Hoque, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Long-term follow-up of real-world teclistamab therapy for relapsed/refractory multiple myeloma from the IMWG Immunotherapy Working Group Committee
    Meeting Abstract

    Tan, C. R.; Asoori, S.; Nemirovsky, D.; Derkach, A.; Brunaldi, L.; Popat, R.; Lau, C.; Kastritis, E.; Martínez-Lopez, J.; Bansal, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NGS MRD negativity on day 28 after brexu cel in adults with R/R ALL is associated with favorable progression free survival
    Meeting Abstract

    Valtis, Y. K.; Nemirovsky, D.; Devlin, S. M.; Roloff, G. W.; Aldoss, I.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Advani, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Derivation and external validation of a venous thromboembolism risk prediction model in patients with acute lymphoblastic leukemia receiving asparaginase therapy
    Meeting Abstract

    Anderson, D. R.; Gangaraju, R.; Sedhom, W.; Hamulyak, E. N.; Wang, T. F.; O'Dwyer, K. M.; Carney, B. J.; Muthiah, C.; Liedtke, M.; Badar, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Imaging predictors of intracerebral hemorrhage in patients with brain tumors treated with anticoagulation
    Meeting Abstract

    Barnea, R.; Naftali, J.; Hamulyak, E. N.; Peseski, A. M.; Wang, T. F.; Kreuziger, L. B.; Iyengar, V.; Carney, B. J.; Özdemir, B.; Serrano, R. D. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD)-adapted duration of front-line venetoclax and obinutuzumab treatment for fit patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Mato, A. R.; Zelenetz, A. D.; Park, J. H.; Geyer, M. B.; Derkach, A.; Nemirovsky, D.; Islam, P.; Falchi, L.; Palomba, M. L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune-MRD status informs tumor-MRD outcome prognostication in multiple myeloma patients on lenalidomide maintenance
    Meeting Abstract

    Firestone, R. S.; Simhal, A. K.; McAvoy, D.; Jurgens, E. M.; Garcés, J. J.; Nemirovsky, D.; Derkach, A.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Outpatient vs inpatient HiDA consolidation for AML: The MSKCC experience
    Meeting Abstract

    Boussi, L.; Burton, H.; Derkach, A.; Nemirovsky, D.; Ciervo, J.; Tallman, M. S.; Stein, E. M.; Cai, S.
    Blood (2024)

    Fulltext@MSK | Save